Resistance to cancer therapy is a major barrier to cancer management. Conventional views
have proposed that acquisition of resistance may result from genetic mutations. However …

Colorectal cancer is one of the most common cancers worldwide with high mortality. Distant
metastasis and relapse are major causes of patient death. Cancer stem cells (CSCs) play a …

Cancer stem cells (CSCs), the subpopulation of cancer cells, have the capability of
proliferation, self-renewal, and differentiation. The presence of CSCs is a key factor leading …

Background The role of M0 macrophages and their related genes in the prognosis of
hepatocellular carcinoma (HCC) remains poorly characterized. Methods Multidimensional …

Colorectal cancer (CRC) is a common malignant tumor of digestive system. Its incidence
rate and mortality rate ranks the third among all the malignant tumors. The objective of this …

ABSTRACT The enrichment of Enterotoxigenic Bacteroides fragilis (ETBF) has been
identified in CRC patients and associated with worse prognosis. Cancer stem cells (CSCs) …

Anti-angiogenic therapy has been successfully applied to treat colorectal cancer (CRC).
Ginsenoside Rg3, derived from the Chinese herb ginseng, has anti-vascularization effects …

Introduction: Metastasis and drug resistance contribute substantially to the poor prognosis of
colorectal cancer (CRC) patients. However, the epigenetic regulatory mechanisms by which …

Colorectal cancer stem cells (CSCs) have the potential for self-renewal, proliferation, and
differentiation. And LGR5 is a stem cell marker gene of colorectal cancer. Curcumin can …

Background Colorectal adenoma (CA), especially high-risk CA (HRCA), is a precancerous
lesion with high prevalence and recurrence rate and accounts for about 90% incidence of …